Evidence map›Paper›PMID 36060086›Full record

ArticleWorld journal of nuclear medicine2022

The Vital Role of

Tejasvini Singhal, Parneet Singh, Hardik Veerwal, Manishi L Narayan

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of nuclear medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tejasvini SinghalDepartment of Nuclear Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Parneet SinghDepartment of Nuclear Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Hardik VeerwalDepartment of Nuclear Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Manishi L NarayanDepartment of Nuclear Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.ORCID 0000-0002-1470-4098

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paragangliomas (PGLs) are extra-adrenal neuroendocrine tumors. PGL of the urinary bladder are very rare and commonly present with features of hypertensive crisis, headache, syncope, and other symptoms of sympathetic excess. A few of these tumors are silent at the presentation. Here, we report a case of a urinary bladder PGL, presenting with lower abdominal pain.

Indexed as

131 I MIBGbladder PGLneuroendocrine tumorparagangliomaurinary bladder

Identifiers

PMID36060086
PMCPMC9436520

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.